Decentralized Clinical Trials (DCT)

Watch this webinar for tips on how to ensure research continuity during COVID-19 by running your trial with a more decentralized approach.

Learn why myTomorrows utilizes Castor to monitor treatment and assess benefit/risk its users, connecting patients with expanded trial access.

Hoboken, New Jersey: March 10, 2021: Castor, a leading provider of clinical trial technology, today announced the signing…

This playbook is a tool for sponsors and CROs who want to leverage DCT technology to support remote interactions in their clinical studies.

COVID-19 changed the conversation around enrollment and recruitment for clinical trials. Learn how eConsent is helping researchers do more despite restrictions.

Hoboken, New Jersey: December 17, 2020: Castor, a leading provider of clinical trial technology, today announced the launch…

In September 2020, Castor CEO Derk Arts, MD, Ph.D., led a webinar on electronic informed consent (eConsent) challenges…

Industry veterans from leading life sciences companies including Johnson & Johnson, Biogen, and Medtronic, will support the Company’s…

This playbook is a tool for sponsors and CROs who want to leverage DCT technology to support remote interactions in their clinical studies.

Though technologies that support decentralized clinical trials (DCT) have been readily available for years, meaningful industry adoption has…